Literature DB >> 1401202

Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens.

M M Reid1, P W Saunders, N Bown, C R Bradford, Z T Maung, A W Craft, A J Malcolm.   

Abstract

AIMS: To describe the histological appearances of bone marrow infiltrated with rhabdomyosarcoma at presentation and to determine their value in establishing the diagnosis.
METHODS: Patients presenting over seven years in the northern health region of England with rhabdomyosarcoma were studied. Bone marrow aspirates and trephine biopsy specimens taken at presentation were examined.
RESULTS: Seven of 32 patients with rhabdomyosarcoma had bone marrow infiltration, resulting in marrow failure in all cases, at diagnosis. The diagnosis was established in these seven by the typical cytological appearances and immunophenotype of the infiltrating cells (all seven patients) and cytogenetic abnormalities (three patients). Histological examination of the bone marrow showed a pseudoalveolar pattern with fibrous septal bands, enlarged vascular channels, and lack of cohesion of the tumour cells within the subdivided aggregates in all seven. In four cases multinucleate giant cells, often with peripherally sited nuclei, were found.
CONCLUSIONS: These histological features of infiltrated marrow are so characteristic that the diagnosis of alveolar rhabdomyosarcoma can be made, or at least suspected, in many cases even without recourse to technically difficult and expensive further investigations. Bone marrow biopsy should be a routine part of the investigation of patients with bone marrow failure and will be of particular value in the diagnosis of those with disseminated alveolar rhabdomyosarcoma.

Entities:  

Mesh:

Year:  1992        PMID: 1401202      PMCID: PMC495098          DOI: 10.1136/jcp.45.9.759

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site: a retrospective study of ten pediatric cases.

Authors:  E Etcubanas; S Peiper; S Stass; A Green
Journal:  Med Pediatr Oncol       Date:  1989

2.  International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Authors:  G M Brodeur; R C Seeger; A Barrett; F Berthold; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman
Journal:  J Clin Oncol       Date:  1988-12       Impact factor: 44.544

3.  Bone marrow metastases in disseminated alveolar rhabdomyosarcoma: case report with ultrastructural study and review.

Authors:  D W Henderson; J L Raven; J A Pollard; M N Walters
Journal:  Pathology       Date:  1976-10       Impact factor: 5.306

4.  Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors.

Authors:  J A Fletcher; H P Kozakewich; F A Hoffer; J M Lage; N Weidner; R Tepper; G S Pinkus; C C Morton; J M Corson
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

5.  A disseminated alveolar rhabdomyosarcoma in a 9-year-old boy disclosed by chromosomal translocation (2;13) (q35;q14)

Authors:  B Brichard; J Ninane; S Gosseye; C Verellen-Dumoulin; C Vermylen; J Rodhain; G Cornu
Journal:  Pediatr Hematol Oncol       Date:  1991 Jul-Sep       Impact factor: 1.969

  5 in total
  5 in total

1.  Massive bone marrow involvement by clear cell variant of rhabdomyosarcoma.

Authors:  Prashant Jani; C Ye Charles
Journal:  Indian J Pediatr       Date:  2009-01-05       Impact factor: 1.967

2.  Rapid diagnosis of malignancy using flow cytometry.

Authors:  M M Reid
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 3.  Alveolar rhabdomyosarcoma with multiple distal metastases. A case report and review of literature.

Authors:  Debojyoti Sarkar; Sayantan Ray; Manjari Saha; Prantar Chakrabarti; Prantari Chakrabarti
Journal:  BMJ Case Rep       Date:  2012-09-03

4.  A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor.

Authors:  Jason B Kern; Anselm Hii; Matthew J Kruse; Zsolt Szabo; Pedram Argani; Michele K Hibbard; Douglas E Gladstone; Christian Meyer; Rui Zheng; Michael J Borowitz; Amy S Duffield
Journal:  Int J Surg Pathol       Date:  2014-10-10       Impact factor: 1.271

5.  Destruction of the craniofacial skeleton in the child caused by an orbital tumor.

Authors:  Grzegorz Goncerz; Janusz Skrzat; Małgorzata Kołodziej; Jerzy Walocha
Journal:  Childs Nerv Syst       Date:  2014-09-27       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.